glp 1 in spain obesity GLP-1 Receptor Agonist Market Size
Description
Tirzepatide: First approval
If so, the two types of heart failure may be very similar, except that the cause of heart failure with a preserved ejection fraction may not be the same as that with a reduced ejection fraction
Forti, E
While hyperkalaemia occurred more frequently with finerenone than with placebo, this was often mild or moderate and resulted in few drug discontinuations (2.3% vs 0.9%, respectively), despite study participants also being on maximum-tolerated RAS inhibitor therapy
The headline is never the beginning
